Nonalcoholic steatohepatitis (NASH) is an increasingly common cause of chronic liver disease worldwide. Currently, no specific pharmacologic therapy has been shown to treat NASH effectively. Because ...

The second study, by Dr Yaping Xu (Takeda Pharmaceuticals) and colleagues, was a retrospective analysis of the US healthcare plan database i3 Innovus. Xu et al report that risk of stroke and MI were ...

New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS(R) ...

Amsterdam, The Netherlands, Sept. 19, 2007 -- New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further ...

Please provide your email address to receive an email when new articles are posted on . Adults with prediabetes and cerebrovascular disease assigned pioglitazone therapy were more likely to sustain a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Adults with type 2 diabetes randomly ...

Actos (pioglitazone) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as an oral tablet that’s taken once per day. Actos is used to help manage blood sugar levels in adults ...

Orlando FL, June 5, 2004 – Type 2 diabetes and hypertension are commonly associated conditions, both of which carry an increased risk of cardiovascular disease. Results of a large, open-label, ...